The NSCLC therapeutics market is set to nearly double—growing from US $33.9 B in 2024 to approximately US $66 B by 2032—at a CAGR of about 10–11%, driven by rising incidence and innovative treatments https://www.datamintelligence.com/research-report/non-small-cell-lung-cancer-therapeutics-market